Raltitrexed
Specifications
112887-68-0CAS Number
652-997-2EC Number
(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acidIUPAC Name
C21H22N4O6SChemical Formula
458.5 g/molMolecular Weight
Raltitrexed; 112887-68-0; ZD1694; ZD-1694; ICI-D1694; D-1694; ZD-16; (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid; DTXSID0046482; ICI D1694; D1694; FCB9EGG971; D 1694; N-(5-(((3,4-Dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thenoyl)-L-glutamic acid; N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid; DTXCID8026482; L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)-; N-(5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic acid; raltitrexedum; (2S)-2-((5-(methyl-((2-methyl-4-oxo-1H-quinazolin-6-yl)methyl)amino)thiophene-2-carbonyl)amino)pentanedioic acid; RefChem:930549; L01BA03; ICI-D-1694; MFCD00864168; NSC-639186; C21H22N4O6S; CHEBI:5847; CHEMBL225071; (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid; (S)-2-(5-(methyl((2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid; NCGC00229704-01; (2S)-2-[(5-{methyl[(2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid; (5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carbonyl)-L-glutamic acid; (S)-2-(5-(methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid; L-Glutamic acid, N-[[5-[[(3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-; D16; N-[[5-[[(1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid; ZD 1694; CAS-112887-68-0; Raltitrexed (Tomudex); UNII-FCB9EGG971; Raltitrexed (JAN/USAN/INN); 1hvy; 2kce; 2tsr; (S)-2-(5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)-methyl)amino)thiophene-2-carboxamido)pentanedioic acid; ZN-D1694; KS-5069; ZD1694; Raltitrexed; RALTITREXED [MI]; RALTITREXED [INN]; RALTITREXED [JAN]; RALTITREXED [USAN]; SCHEMBL7438; SCHEMBL7439; RALTITREXED [MART.]; RALTITREXED [WHO-DD]; MLS001424225; MLS006010125; Raltitrexed [USAN:INN:BAN]; GTPL7403; orb1226950; orb1300600; SCHEMBL29454789; SCHEMBL29490413; BDBM18795; 1i00; IVTVGDXNLFLDRM-HNNXBMFYSA-N; HMS2052I03; HMS3715P08; N-(5-(N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid;(S)-2-(5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid; Tox21_112237; BDBM50027655; EBC-17119; NSC639186; s1192; AKOS015894877; AKOS015994729; Tox21_112237_1; CCG-101075; CCG-221273; DB00293; FR27671; NC00325; NCGC00229704-03; NCGC00229704-05; NCGC00263534-02; HY-10821; NCI60_013008; SMR000469217; SMR002529608; NS00069368; R0208; R0245; SW197705-2; T6632; D01064; AB00698356-05; EN300-27032179; SR-01000763351; SR-01000763351-3; BRD-K89839824-001-01-2; BRD-K89839824-001-05-3; BRD-K89839824-001-06-1; Q15304877; N-(5-{Methyl[(2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl]amino}thiophene-2-carbonyl)-L-glutamic acid; N-[(5-{methyl[(2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)carbonyl]-L-glutamic acidSynonyms
